|
|
|
|
LEADER |
01264nam a2200265 u 4500 |
001 |
EB001897122 |
003 |
EBX01000000000000001060127 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200523 r ||| eng |
020 |
|
|
|a 9789241550598
|
245 |
0 |
0 |
|a WHO guidelines for the use of thermal ablation for cervical pre-cancer lesions
|h Elektronische Ressource
|
260 |
|
|
|a Geneva
|b World Health Organization
|c [2019], 2019
|
300 |
|
|
|a 1 PDF file (108 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Precancerous Conditions / diagnosis
|
653 |
|
|
|a Electrocoagulation
|
653 |
|
|
|a Uterine Cervical Neoplasms / diagnosis
|
653 |
|
|
|a Cervical Intraepithelial Neoplasia / surgery
|
710 |
2 |
|
|a World Health Organization
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549182
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The objectives of these guidelines are 1. to provide evidence-based guidance on the use of thermal ablation to treat cervical precancer; and2. to support countries to update their national guidelines for the use of thermal ablation for cervical precancer
|